Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) EV to EBIT (2011 - 2013)

Updated

Kazia Therapeutics' (KZIA) EV to EBIT was 1.76 for fiscal Q4 2013 (quarter ended Aug 30, 2013).

Analysis

Kazia Therapeutics (KZIA) EV to EBIT (2011 - 2013) Analysis & Trends

Over the twelve months ended Aug 30, 2013, Kazia Therapeutics' EV to EBIT came in at 0.61; for FY2010 (ended Jun 30, 2010), it was -7.31.

  • By fiscal year, EV to EBIT came in at 3.26 in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 3.01
Aug 30, 2013 1.30
Dec 31, 2012 0.39
Dec 31, 2011 -0.76
API Access

Kazia Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=KZIA&period=max&api_key=YOUR_API_KEY